Literature DB >> 20646690

Poor response cycles: when should we cancel? Comparison of outcome between egg collection, intrauterine insemination conversion, and follow-up cycles after abandonment.

James D M Nicopoullos1, Hossam Abdalla.   

Abstract

OBJECTIVE: To determine optimal management with one or two mature follicles after stimulation.
DESIGN: Retrospective analysis.
SETTING: Lister fertility clinic. PATIENT(S): A total of 1,350 IVF/intracytoplasmic sperm injection cycles (7.3% of total) during 1998-2009 were found to have one or two mature follicles. INTERVENTION(S): Group 1 (n = 807) comprised those who proceeded to vaginal egg collection (VEC) (59.8%; outcome per egg collection), group 2 (n=248) those who converted to IUI (18.4%; outcome per insemination) and group 3 (n=259) those who abandoned the current cycle (21.9%; outcome per abandoned cycle in first subsequent cycle). MAIN OUTCOME MEASURE(S): Live birth rate, clinical pregnancy rate, and biochemical pregnancy rate. RESULT(S): Biochemical pregnancy rates of 13.1%, 4.9%, and 9.7%, clinical pregnancy rates of 8.1%, 3.6%, and 7.2%, and ongoing pregnancy rates of 6.8%, 2.0%, and 5.5% were achieved in groups 1, 2, and 3, respectively. All pregnancy outcomes were significantly higher after VEC (group 1) than for those converted to IUI (group 2), and all pregnancy outcomes were higher with borderline significance in group 3 vs. group 2. There was no significant difference in outcome between groups 1 and 3. CONCLUSION(S): Our data suggest that for such poor responders, proceeding to VEC may represent their best chance of successful outcome. Conversion to IUI offers the poorest outcome, and despite the potential for improvements in cycle protocol, abandoning and a further attempt does not improve outcome (using abandoned cycle as the denominator).
Copyright © 2011 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20646690     DOI: 10.1016/j.fertnstert.2010.05.030

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  6 in total

1.  Cost-effectiveness analysis comparing continuation of assisted reproductive technology with conversion to intrauterine insemination in patients with low follicle numbers.

Authors:  Bo Yu; Sunni Mumford; G Donald Royster; James Segars; Alicia Y Armstrong
Journal:  Fertil Steril       Date:  2014-06-18       Impact factor: 7.329

2.  Two successful pregnancies achieved by converting an in vitro fertilization cycle to an intrauterine insemination cycle in five cases with documented premature ovulation.

Authors:  Kubilay Vicdan; Cem Akarsu; Eran Sözen; Burcu Buluç; Deniz K Üstündağ; Kutay Biberoğlu
Journal:  J Turk Ger Gynecol Assoc       Date:  2016-12-01

3.  Follicular sensitivity index (FSI): a novel tool to predict clinical pregnancy rate in IVF/ICSI cycles.

Authors:  AbdelGany M A Hassan; Mohamed M M Kotb; Ahmed M A AwadAllah; Nesreen A A Shehata; Amr Wahba
Journal:  J Assist Reprod Genet       Date:  2017-07-03       Impact factor: 3.412

4.  Bivariate analysis of basal serum anti-Müllerian hormone measurements and human blastocyst development after IVF.

Authors:  E Scott Sills; Gary S Collins; Adam C Brady; David J Walsh; Kevin D Marron; Alison C Peck; Anthony P H Walsh; Rifaat D Salem
Journal:  Reprod Biol Endocrinol       Date:  2011-12-02       Impact factor: 5.211

5.  Bone morphogenetic protein-15 in follicle fluid combined with age may differentiate between successful and unsuccessful poor ovarian responders.

Authors:  Yan-Ting Wu; Ting-Ting Wang; Xi-Jing Chen; Xiao-Ming Zhu; Min-Yue Dong; Jian-Zhong Sheng; Chen-Ming Xu; He-Feng Huang
Journal:  Reprod Biol Endocrinol       Date:  2012-12-26       Impact factor: 5.211

6.  ConFIRM trial - conversion of in vitro fertilization cycles to intrauterine inseminations in patients with a poor ovarian response to stimulation: a protocol for a multicentric, prospective randomized trial.

Authors:  Léa Delbos; Elsa Parot-Schinkel; Hady El Hachem; Guillaume Legendre; Philippe Descamps; Lisa Boucret; Véronique Ferré-L'Hotellier; Pauline Jeanneteau; Cécile Dreux; Catherine Morinière; Pascale May-Panloup; Pierre-Emmanuel Bouet
Journal:  Trials       Date:  2018-10-17       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.